BioSpace News Archive

Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States

Canopy Growth Corporation has completed a legal transfer of cannabis products to a research partner in the United States.

October 9, 2018
·
5 min read
Deals

Aurora Cannabis Announces Application to List on the NYSE

Aurora Cannabis Inc. announced today that the Company has filed an application to list its common shares on the New York Stock Exchange (“NYSE”).

October 9, 2018
·
5 min read
Business

Cardiovascular Systems, Inc. to Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30

Live Webcast at 3:45 p.m. CT (4:45 p.m. ET)

October 9, 2018
·
1 min read
Drug Development

AVEO Oncology to Present Updated Interim Results from the Phase 2 Portion of the TiNivo Study of Tivozanib and Nivolumab (OPDIVO®) in RCC at the ESMO 2018 Annual Congress

AVEO Oncology today announced that updated interim data from the Phase 2 portion of the TiNivo trial of tivozanib and nivolumab (OPDIVO®) in advanced renal cell carcinoma will be presented at the European Society of Medical Oncology (ESMO) 2018 Annual Congress being held October 19-23, 2018 in Munich, Germany.

October 9, 2018
·
5 min read
Business

Health2047 Spins out First Mile Care to Reverse Prediabetes in the U.S.

With $2M in Seed Funding, First Mile Care Will Build a Scalable On-Demand Preventative Care Platform

October 9, 2018
·
4 min read
Business

Appili Therapeutics Appoints Seasoned Infectious Disease Global Drug Development Executive Dr. Theresa Matkovits to Its Board of Directors

ContraVir Pharmaceuticals COO Brings Extensive Infectious Disease-focused Drug Development Experience to Appili’s Board

October 9, 2018
·
4 min read
Pharm Country

‘Aesthetic Surgery Journal’ Study Suggests Most Aesthetically Pleasing Outcomes From Buttock Augmentation Are Linked To Thicker, Wider Thighs

Findings Reflect a Fundamental Shift in Aesthetic Trends and Desire for Fuller Curves

October 9, 2018
·
4 min read
Policy

Australian Health Manufacturer ATP Science Achieves ISO 9001 Certification

ATP Science Pty Ltd has reached a strategic milestone in achieving ISO 9001 Certification.

October 9, 2018
·
1 min read
Policy

Health Canada Approves New Indications for XELJANZ in Ulcerative Colitis (UC) & Psoriatic Arthritis (PsA)

XELJANZ, an oral therapy, is the first and only Janus kinase (JAK) inhibitor approved by Health Canada for Rheumatoid Arthritis (RA), UC and PsA

October 9, 2018
·
3 min read
Genetown

Quanterix’ Simoa Technology Powers Record Number of Presentations and Poster Sessions at ECTRIMS 2018

International multiple sclerosis conference features 35 new studies using Simoa technology demonstrating potential of Neurofilament light chain (NfL) as a reliable and sensitive disease biomarker

October 9, 2018
·
4 min read